Literature DB >> 20874088

Improved prediction of HIV‐1 coreceptor usage with sequence information from the second hypervariable loop of gp120.

Alexander Thielen1, Nadine Sichtig, Rolf Kaiser, Jeffrey Lam, P Richard Harrigan, Thomas Lengauer.   

Abstract

BACKGROUND: Human immunodeficiency virus type 1 (HIV‐1) uses the CD4 receptor and a coreceptor to gain cell entry. Coreceptor usage is mainly determined by the V3 loop of gp120. Therefore, coreceptor usage is currently inferred from the genotype on the basis of V3 alone. However, several mutations outside V3 have been repeatedly reported to influence coreceptor usage. In this study, the impact of the V2 loop on coreceptor usage prediction was analyzed.
METHODS: Sequences were analyzed for differences at specific positions and position‐independent features with the Fisher exact and Student t tests. Prediction models were trained with support vector machines and evaluated in cross‐validation on clonal data. Models trained on the clonal data set were validated on 2 clinical data sets.
RESULTS: Several mutations and position‐independent features within V2 were statistically significantly different between R5 and X4 viruses. Cross‐validation on the clonal data set revealed a statistically significantly higher area under the receiver operating characteristic curve if features of both loops were used, compared with those using only V2 or V3 alone. Similar results were found with clinically derived data sets.
CONCLUSIONS: The ability of the V2 loop to improve coreceptor usage prediction has been shown in a large data set. Utilization of this information can lead to considerable improvements in the prediction of coreceptor use both on clonal data sets and on clinically derived data sets.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20874088     DOI: 10.1086/656600

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Impact of mutations outside the V3 region on coreceptor tropism phenotypically assessed in patients infected with HIV-1 subtype B.

Authors:  Laura Monno; Annalisa Saracino; Luigia Scudeller; Grazia Punzi; Gaetano Brindicci; Maurantonio Altamura; Antonella Lagioia; Nicoletta Ladisa; Gioacchino Angarano
Journal:  Antimicrob Agents Chemother       Date:  2011-08-29       Impact factor: 5.191

2.  Effect of Amino Acid Substitutions Within the V3 Region of HIV-1 CRF01_AE on Interaction with CCR5-Coreceptor.

Authors:  Sayamon Hongjaisee; Martine Braibant; Francis Barin; Nicole Ngo-Giang-Huong; Wasna Sirirungsi; Tanawan Samleerat
Journal:  AIDS Res Hum Retroviruses       Date:  2017-06-12       Impact factor: 2.205

Review 3.  Bioinformatic analysis of HIV-1 entry and pathogenesis.

Authors:  Benjamas Aiamkitsumrit; Will Dampier; Gregory Antell; Nina Rivera; Julio Martin-Garcia; Vanessa Pirrone; Michael R Nonnemacher; Brian Wigdahl
Journal:  Curr HIV Res       Date:  2014       Impact factor: 1.581

4.  A diagnostic HIV-1 tropism system based on sequence relatedness.

Authors:  Suzanne Edwards; Heinz Stucki; Joëlle Bader; Vincent Vidal; Rolf Kaiser; Manuel Battegay; Thomas Klimkait
Journal:  J Clin Microbiol       Date:  2014-12-10       Impact factor: 5.948

5.  Evolution of HIV-1 coreceptor usage and coreceptor switching during pregnancy.

Authors:  Doris G Ransy; Alena Motorina; Natacha Merindol; Bertine S Akouamba; Johanne Samson; Yolanda Lie; Laura A Napolitano; Normand Lapointe; Marc Boucher; Hugo Soudeyns
Journal:  AIDS Res Hum Retroviruses       Date:  2013-10-25       Impact factor: 2.205

6.  Genotypic prediction of HIV-1 subtype D tropism.

Authors:  Stéphanie Raymond; Pierre Delobel; Marie-Laure Chaix; Michelle Cazabat; Stéphanie Encinas; Patrick Bruel; Karine Sandres-Sauné; Bruno Marchou; Patrice Massip; Jacques Izopet
Journal:  Retrovirology       Date:  2011-07-13       Impact factor: 4.602

7.  Selected amino acid mutations in HIV-1 B subtype gp41 are associated with specific gp120v₃ signatures in the regulation of co-receptor usage.

Authors:  Salvatore Dimonte; Fabio Mercurio; Valentina Svicher; Roberta D'Arrigo; Carlo-Federico Perno; Francesca Ceccherini-Silberstein
Journal:  Retrovirology       Date:  2011-05-12       Impact factor: 4.602

8.  A Conserved Glycan in the C2 Domain of HIV-1 Envelope Acts as a Molecular Switch to Control X4 Utilization by Clonal Variants with Identical V3 Loops.

Authors:  Francesca Lombardi; Kyle J Nakamura; Thomas Chen; Edwin R Sobrera; Nicole H Tobin; Grace M Aldrovandi
Journal:  PLoS One       Date:  2015-06-17       Impact factor: 3.240

9.  An expanded model of HIV cell entry phenotype based on multi-parameter single-cell data.

Authors:  Katarzyna Bozek; Manon Eckhardt; Saleta Sierra; Maria Anders; Rolf Kaiser; Hans-Georg Kräusslich; Barbara Müller; Thomas Lengauer
Journal:  Retrovirology       Date:  2012-07-25       Impact factor: 4.602

10.  Hybrid approach for predicting coreceptor used by HIV-1 from its V3 loop amino acid sequence.

Authors:  Ravi Kumar; Gajendra P S Raghava
Journal:  PLoS One       Date:  2013-04-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.